Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Tian-li Xu"'
Autor:
Wang-shu Liu, Meng-jie Tang, Tian-li Xu, Jian-bin Su, Xue-qin Wang, Feng Xu, Dong-mei Zhang, Qing Zhu, Jie Cao, Hong Wang
Publikováno v:
Diabetology & Metabolic Syndrome, Vol 12, Iss 1, Pp 1-8 (2020)
Abstract Background The role of serum fibroblast growth factor 19 (FGF19) in arteriosclerosis is not well known. In the present study, we aimed to explore whether serum FGF19 levels were related to arteriosclerosis parameters, including arterial stif
Externí odkaz:
https://doaj.org/article/11f35fb12fe0400f98f23930601756e6
Publikováno v:
Diabetology & Metabolic Syndrome, Vol 11, Iss 1, Pp 1-8 (2019)
Abstract Background Fibroblast growth factor 19 (FGF19) takes part in maintaining the balance of glycolipids and may be involved in regulating the secretory activity of islet beta cells in patients with type 2 diabetes. This study aimed to evaluate t
Externí odkaz:
https://doaj.org/article/16ab8f651af84c7c9b9f99219c918b9a
Publikováno v:
Journal of the Franklin Institute. 360:1672-1689
Background The ApoB/ApoA-1 (ApoB/A1) ratio is a predictor of atherosclerotic vascular disease. In this study, we aimed to explore whether ApoB/A1 ratio is related to arteriosclerosis parameters, including subclinical atherosclerosis and arterial stif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4173a84bd11fa4555236a46070f3ebe7
https://doi.org/10.21203/rs.3.rs-2089188/v1
https://doi.org/10.21203/rs.3.rs-2089188/v1
Autor:
Feng Zhang, Jie Hao, Yu Yao, Kai Yang, Tian Li Xu, Rongqing Qin, Baoshan Liu, Pin Zhou, Xiaoqing Chen
Publikováno v:
World Neurosurgery. 122:180-189
Objective To compare the clinical efficacy and safety between minimally invasive and traditional open transforaminal lumbar interbody fusion in the treatment of single-level spondylolisthesis grades 1 and 2. Methods This was a systematic review and m
Publikováno v:
Diabetology & Metabolic Syndrome
Diabetology & Metabolic Syndrome, Vol 11, Iss 1, Pp 1-8 (2019)
Diabetology & Metabolic Syndrome, Vol 11, Iss 1, Pp 1-8 (2019)
Background Fibroblast growth factor 19 (FGF19) takes part in maintaining the balance of glycolipids and may be involved in regulating the secretory activity of islet beta cells in patients with type 2 diabetes. This study aimed to evaluate the relati